Explore life science companies operating throughout Greater London, from biotechnology startups to global pharmaceutical organisations.
AI-designed regulatory DNA sequences to boost biologics manufacturing yields
Genosys Bio is a UK biotechnology company developing AI models that learn the regulatory grammar of DNA to design improved promoter and terminator sequences for biologics manufacturing. Its platform optimises gene expression in CHO cell lines, helping increase protein yields without changing existing cells, processes…
Computational cell models for novel drug target discovery
Oppilotech is a UK biotechnology company that uses systems biology and machine learning to build high-resolution computational models of cells and bacteria. Its proprietary platform simulates biochemical pathways to identify viable drug targets and generate first-in-class discovery programmes. The company's primary…
Point-of-care HPV self-testing for cervical cancer screening
10zyme is an early-stage medical technology company developing a point-of-care self-test for high-risk human papillomavirus, integrating synthetic biology with machine learning to deliver instant results without laboratory processing. Its test screens for all 14 high-risk HPV types linked to cervical cancer,…
Industry collaboration network for biopharmaceutical manufacturing and operations
BioPhorum is a UK-based membership organisation that brings together senior leaders and subject matter experts from global biopharmaceutical manufacturers, CDMOs, and suppliers to collaborate on shared operational and technology challenges. Working through structured groups covering drug substance, fill-finish, cell…
Leather-like textiles made from brewery spent grain protein
Arda Biomaterials develops leather alternatives using protein extracted from spent grain, a by-product of brewing and distilling. The company modifies these proteins to create materials that mimic the fibrous structure of animal leather, without animal-derived or petrochemical components. Its products are aimed at…
National institute researching dementia and neurodegenerative disease across the UK
The UK Dementia Research Institute is the UK's leading national institute dedicated to transforming outcomes for people affected by dementia and neurodegenerative conditions. Its central Hub at University College London coordinates seven research Centres hosted across leading UK universities, working towards new…
AI platform combining retinal imaging and genomics for inherited eye disease diagnosis
Eye2Gene is an AI-powered precision ophthalmology platform combining retinal imaging with genomic analysis to accelerate diagnosis of inherited retinal diseases. Using a neural network ensemble trained on tens of thousands of multimodal retinal scans, the platform predicts the likely causative gene behind a patient's…
Therapeutics and blood biomarker tests for ALS
Vesalic develops therapeutic and diagnostic approaches for amyotrophic lateral sclerosis (ALS), focusing on the potential role of metabolic dysfunction outside the nervous system. Its preclinical programmes include a treatment candidate designed to address toxic cargo carried by exosomes to motor neurons, alongside a…
AI operating system connecting pharma drug development decisions end-to-end
Perceptic is a UK software company that has built an AI platform connecting decision-making across the drug development lifecycle. Its system unifies external asset scouting, scientific evaluation of licensing candidates, indication selection for clinical trials, and clinical data analysis within a single, traceable…
Nitric oxide therapeutics developer for infectious and respiratory disease
30 Technology is a clinical-stage biopharmaceutical company developing nitric oxide-generating therapies for the treatment of antimicrobial-resistant infections and chronic respiratory diseases. The company’s proprietary platform enables controlled, sustained delivery of nitric oxide across inhaled, topical and powder…
Next-generation ADC linker chemistry for precision cancer therapeutics
Siftr Bio is a biotechnology company developing novel linker chemistry for antibody-drug conjugates. Current ADC linkers have limited diversity and insufficient selectivity, contributing to off-target toxicity that restricts their therapeutic application. Siftr's platform screens enzyme-responsive linker candidates…